Oxygenta Pharmaceutical Ltd Peer Comparison
OXYGENTAPHLTD · Healthcare · Current price
Peers tracked
16
Oxygenta Pharmaceutical Ltd P/E
-15.2x
Sector
Healthcare
Oxygenta Pharmaceutical Ltd vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,840 | 39.1x | 4,41,566 |
| DIVI S LABORATORIES LTD | ₹9,322 | 69.1x | 2,47,479 |
| TORRENT PHARMACEUTICALS L | ₹4,965.5 | 72.9x | 1,68,098 |
| ZYDUS LIFESCIENCES LTD | ₹1,119.1 | 22.0x | 1,12,612 |
| CIPLA LTD | ₹1,366 | 30.3x | 1,10,332 |
| LAURUS LABS LIMITED | ₹1,969 | 92.8x | 1,06,200 |
| AUROBINDO PHARMA LTD | ₹1,679.8 | 25.9x | 97,564 |
| DR. REDDY S LABORATORIES | ₹1,165.5 | 26.8x | 97,276 |
| LUPIN LIMITED | ₹2,095 | 20.6x | 95,784 |
| MANKIND PHARMA LIMITED | ₹2,280 | 53.7x | 94,138 |
| GLENMARK PHARMACEUTICALS | ₹2,419.2 | 45.5x | 68,295 |
| BIOCON LIMITED. | ₹390.65 | 175.9x | 62,895 |
Oxygenta Pharmaceutical Ltd versus its peers
Oxygenta Pharmaceutical Ltd operates in the Healthcare space alongside 16 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of -15.2x may be cheap in one industry and expensive in another.
More on Oxygenta Pharmaceutical Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.